-
1
-
-
43149095105
-
The role of mullerian inhibiting substance in female reproduction
-
DOI 10.1097/GCO.0b013e3282fe99f2, PII 0000170320080600000011
-
The role of mullerian inhibiting substance in female reproduction. GS Nakhuda, Curr Opin Obstet Gynecol 2008 20 3 257 264 10.1097/GCO.0b013e3282fe99f2 18460940 (Pubitemid 351643513)
-
(2008)
Current Opinion in Obstetrics and Gynecology
, vol.20
, Issue.3
, pp. 257-264
-
-
Nakhuda, G.S.1
-
2
-
-
70449403696
-
Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk
-
10.1093/jnci/djp331. 19820206
-
Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. JF Dorgan FZ Stanczyk BL Egleston LL Kahle CM Shaw CS Spittle AK Godwin LA Brinton, J Natl Cancer Inst 2009 101 21 1501 1509 10.1093/jnci/djp331 19820206
-
(2009)
J Natl Cancer Inst
, vol.101
, Issue.21
, pp. 1501-1509
-
-
Dorgan, J.F.1
Stanczyk, F.Z.2
Egleston, B.L.3
Kahle, L.L.4
Shaw, C.M.5
Spittle, C.S.6
Godwin, A.K.7
Brinton, L.A.8
-
3
-
-
1542619346
-
Transforming Growth Factor-β Superfamily: Evaluation as Breast Cancer Biomarkers and Preventive Agents
-
DOI 10.2174/1568009043481542
-
Transforming Growth Factor-beta superfamily: evaluation as breast cancer biomarkers and preventive agents. V Gupta DP Harkin H Kawakubo S Maheswaran, Curr Cancer Drug Targets 2004 4 2 165 182 10.2174/1568009043481542 15032667 (Pubitemid 38332554)
-
(2004)
Current Cancer Drug Targets
, vol.4
, Issue.2
, pp. 165-182
-
-
Gupta, V.1
Harkin, D.P.2
Kawakubo, H.3
Maheswaran, S.4
-
4
-
-
0034798865
-
Müllerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications
-
DOI 10.1210/er.22.5.657
-
Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. J Teixeira S Maheswaran PK Donahoe, Endocr Rev 2001 22 5 657 674 10.1210/er.22.5.657 11588147 (Pubitemid 32955249)
-
(2001)
Endocrine Reviews
, vol.22
, Issue.5
, pp. 657-674
-
-
Teixeira, J.1
Maheswaran, S.2
Donahoe, P.K.3
-
5
-
-
14744267971
-
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model
-
DOI 10.1073/pnas.0409709102
-
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model. V Gupta JL Carey H Kawakubo A Muzikansky JE Green PK Donahoe DT MacLaughlin S Maheswaran, Proc Natl Acad Sci USA 2005 102 9 3219 3224 10.1073/pnas.0409709102 15728372 (Pubitemid 40328026)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.9
, pp. 3219-3224
-
-
Gupta, V.1
Carey, J.L.2
Kawakubo, H.3
Muzikansky, A.4
Green, J.E.5
Donahoe, P.K.6
MacLaughlin, D.T.7
Maheswaran, S.8
-
6
-
-
0035920103
-
Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo
-
10.1074/jbc.M103092200. 11356848
-
Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo. DL Segev Y Hoshiya AE Stephen M Hoshiya TT Tran DT MacLaughlin PK Donahoe S Maheswaran, J Biol Chem 2001 276 29 26799 26806 10.1074/jbc.M103092200 11356848
-
(2001)
J Biol Chem
, vol.276
, Issue.29
, pp. 26799-26806
-
-
Segev, D.L.1
Hoshiya, Y.2
Stephen, A.E.3
Hoshiya, M.4
Tran, T.T.5
MacLaughlin, D.T.6
Donahoe, P.K.7
Maheswaran, S.8
-
7
-
-
0029549455
-
Molecular aspects of the ontogeny of the pituitary-gonadal axis
-
DOI 10.1071/RD9951025
-
Molecular aspects of the ontogeny of the pituitary-gonadal axis. I Huhtaniemi, Reprod Fertil Dev 1995 7 5 1025 1035 10.1071/RD9951025 8848567 (Pubitemid 26088841)
-
(1995)
Reproduction, Fertility and Development
, vol.7
, Issue.5
, pp. 1025-1035
-
-
Huhtaniemi, I.1
-
8
-
-
0015515388
-
Breast cancer risk profile used in detecting preclinical disease
-
12229379
-
Breast cancer risk profile used in detecting preclinical disease. JAMA 1972 222 12 1484 1485 12229379
-
(1972)
JAMA
, vol.222
, Issue.12
, pp. 1484-1485
-
-
-
9
-
-
33645232747
-
The risk of breast, endometrial and ovarian cancer in users of hormonal preparations
-
10.1111/j.1742-7843.2006.pto-277.x. 16611204
-
The risk of breast, endometrial and ovarian cancer in users of hormonal preparations. L Bernstein, Basic Clin Pharmacol Toxicol 2006 98 3 288 296 10.1111/j.1742-7843.2006.pto-277.x 16611204
-
(2006)
Basic Clin Pharmacol Toxicol
, vol.98
, Issue.3
, pp. 288-296
-
-
Bernstein, L.1
|